Leveraging adaptive implementation strategies to achieve universal coverage of antiretroviral therapy in Senegal
Senegal plans a rapid scale up of HIV treatment for all PLHIV, regardless of CD4 count or viral suppression. Results from HPTN 052, START, and Temprano studies demonstrated the clinical benefit of early treatment. However, limited data exist on how to achieve sustained viral suppression in real world contexts where significant barriers to effective ART delivery, uptake, and adherence persist. Thus, understanding the effectiveness of interventions around early initiation of ART and optimized retention is important for the continued HIV response.
This report summarizes findings from a study Project SOAR conducted to develop and assess the feasibility, fidelity, and cost-effectiveness of a universal coverage of antiretroviral treatment intervention among people living with HIV who are not virally suppressed in Dakar and Ziguinchor, Senegal.